MoneyWorks4Me

Windlas Biotech informs about board meeting intimation

31 Oct 2022 Evaluate
Windlas Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 08/11/2022, to consider and approve Un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2022.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..